Your browser doesn't support javascript.
loading
Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma.
Kurashina, Ryo; Ando, Kiyohiro; Inoue, Masaharu; Izumi, Keita; Maruyama, Riko; Mitani, Kouki; Takenobu, Hisanori; Haruta, Masayuki; Iizuka, Toshihiko; Kamijo, Takehiko; Kageyama, Yukio.
Affiliation
  • Kurashina R; Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Ando K; Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan kiyohiro_ando@saitama-pho.jp.
  • Inoue M; Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Izumi K; Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Maruyama R; Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Mitani K; Department of Urology, Saitama Cancer Center, Saitama, Japan.
  • Takenobu H; Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.
  • Haruta M; Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.
  • Iizuka T; Department of Pathology, Saitama Cancer Center, Saitama, Japan.
  • Kamijo T; Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.
  • Kageyama Y; Department of Urology, Saitama Cancer Center, Saitama, Japan.
Anticancer Res ; 42(2): 1131-1136, 2022 Feb.
Article in En | MEDLINE | ID: mdl-35093916
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Blood Platelets / Lymphocytes / Carcinoma, Transitional Cell / Antibodies, Monoclonal, Humanized Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Anticancer Res Year: 2022 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Blood Platelets / Lymphocytes / Carcinoma, Transitional Cell / Antibodies, Monoclonal, Humanized Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Anticancer Res Year: 2022 Type: Article Affiliation country: Japan